Psychopharmacology in children and adolescents: unmet needs and opportunities
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023
Penta joins CoMeCT, a new European project to boost clinical research preparedness for future infectious disease outbreaks
Core Outcome Measurement Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID) in Children and Young People: An International Delphi Consensus Study “PC-COS Children”
Age-specific transmission dynamics of SARS-CoV-2 during the first two years of the pandemic
How does post COVID differ from other post-viral conditions in childhood and adolescence (0–20 years old)? A systematic review
Penta teams up with IAVI and Achilles Vaccines to develop new treatments for HIV, emerging infections and neglected diseases
🇬🇧 Penta Teams Up with IAVI and Achilles Vaccines to Develop New Treatments for HIV, Emerging Infections and Neglected Diseases
Advancing Paediatric Antibiotic Research: Two New African-European Research Collaborations Tackle Severe Infections in Neonates and Children
🇬🇧 Advancing Paediatric Antibiotic Research: Two New African-European Research Collaborations Tackle Severe Infections in Neonates and Children
Prophylactic Intravenous Acetaminophen in Extremely Premature Infants: Minimum Effective Dose Research by Bayesian Approach
Epidemic graph diagrams as analytics for epidemic control in the data-rich era
Empowering young voices through Penta’s Youth Trial Boards (YTB)
Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa
